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Anaemia (part 1)
Anaemia is the most common haematological abnormality, affecting 
an estimated 1.6 billion people globally. Healthcare workers, particu-
larly general practitioners, regularly encounter patients who present 
with anaemia. 
The causes of anaemia are numerous and varied, necessita ting a 
structured diagnostic approach at presentation. While basic inves-
tigations suffice for most patients presenting with this condition, 
the less common types of anaemia often require expertise and 
more specialised diagnostic tests and equipment. Costs involved in 
infrastructure development and the acquisition of equipment pay 
dividends in the long term in the form of prompt and accurate diag-
nosis and appropriate interventions. However, in resource-challenged 
countries, budgetary constraints limit the scope of investigations and 
management options. This applies particularly to the inherited and 
chronic anaemias that are likely to have a significant (and in some 
instances total) degree of transfusion dependency. 
From the 1990s onwards, South Africa (SA) has faced the following 
unique challenges that have placed added strain on the health budget: 
• A steady influx of visitors for business, employment or health reasons. 
• A rising incidence of HIV and tuberculosis, coupled with limited 
intervention by the health ministry, saw a significant increase in the 
complication rate, especially as patients often seek medical attention at 
an advanced stage of their disease. Anaemia is commonly detected at 
presentation. However, with progression of the disease, complications 
develop and anaemia of increasing severity often supervenes, which 
may require urgent intervention.
These challenges demand innovative approaches, such as sharing of 
resources and expertise between centres and a streamlined referral 
system. Construction of guidelines specific for the SA setting would 
be a step towards standardising treatment protocols and also highlight 
resource constraints with feasible solutions. A working example is the SA 
recommendations for the management of sickle cell disease.[1] 
Numerous approaches to the investigation of anaemia are described 
in the literature; these are generally based on different classifications 
of the subject. In this edition of CME various classification systems 
have been employed to construct a practical approach for the investi-
gation of anaemia. Emphasis is placed on the diagnostic approach, 
broadly touching on pathophysiology and management issues. Given 
the vastness of the subject, it will be split into two parts: part 1, which 
focuses on central causes, i.e. decreased bone marrow output of ery-
throcytes; and part 2, which covers peripheral causes, i.e. peripheral 
loss, destruction or sequestration of erythrocytes. 
An in-depth review of disorders causing anaemia is beyond the 
scope of this two-part CME series. For ease of reference, selected 
tables have been duplicated in both parts.
The authors are indeed privi-
leged to have the opportunity to 
present an overview of this very 
common, yet vast, topic.
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